US 12,084,424 B2Granted

Compounds and compositions for treating conditions associated with NLRP activity

AssigneeNovartis AG

InventorsLuigi Franchi, Shomir Ghosh, Gary Glick, Jason Katz, Anthony William Opipari, Jr., William Roush, Hans Martin Seidel, Dong-Ming Shen, Shankar Venkatraman, David Guenther Winkler

Life of this patent

Estimating the term…

Abstract

In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured: or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A can be as defined anywhere herein.

Claims3

Dependent claims

A compound selected from the group consisting of:

wherein TBS is tert-butyldimethylsilyl and Boc is tert-butyloxy carbonyl, and pharmaceutically acceptable salts thereof.

Dependencies are inferred from the claim text.

Facts

Application: 18/319,630Filed 18 May 2023 · continuation
Priority: 24 Jul 2017
Published: US 2023/0062815 A128 Dec 2023
Granted: 10 Sep 2024
Term ends: Not estimatedThe source records don’t support an estimate.

Classification24 codes

C07D 277/36
With hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals,…:…
C07C 307/06
Diamides of sulfuric acids: having nitrogen atoms of the sulfamide groups bound to acyclic carbon atoms
C07C 381/10
Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00: compounds containing sulfur…
C07D 215/36
With hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals,…:…

Family

Application62/536,271Us provisional application · filed 24 Jul 2017
Application62/573,894Us provisional application · filed 18 Oct 2017
PCT/US2018/043338Parent of this continuation · filed 23 Jul 2018
Application17/496,375Parent of this continuation · filed 7 Oct 2021
US 2023/0416211 A1Pre-grant publication · published 28 Dec 2023
US 11,724,992 B2Parent of this continuation
Application16/632,849Parent of this continuation
US 11,203,579 B2Parent of this continuation
US 2021/0171477 A1Published application
US 2023/0062815 A1Published application
US 12,084,424 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results